GlassScriptPhysician profile
Ari Jonathan Feinberg
NPI 1518426576
$3,120.80
in general payments reported to CMS, 2019-2025
18 companies · $2,111 in 2025
The $2,111 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $147 · 2023: $250 · 2024: $613 · 2025: $2,111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,006 · Travel and Lodging: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,006.13 |
| Travel and Lodging | $967.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $1,555.45 | 2024-2025 | Barostim Neo System |
| Abiomed | $411.11 | 2024-2025 | Impella |
| Abbott Laboratories | $352.71 | 2023-2025 | Diamondback Peripheral, Aveir, Dragonfly Opstar |
| Shockwave Medical, INC | $298.08 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Heartflow, INC. | $124.20 | 2024 | |
| Novartis Pharmaceuticals Corporation | $58.65 | 2024-2025 | |
| Medtronic, INC. | $46.81 | 2024-2025 | Chocolate Pta Balloon Catheter, Aurora Ev-Icd Mri Surescan |
| Amgen INC. | $45.05 | 2024-2025 | Repatha |
| Merck Sharp & Dohme LLC | $30.67 | 2024-2025 | Verquvo |
| Edwards Lifesciences Corporation | $27.69 | 2023 | Mitris Resilia Mitral Valve |
| Scpharmaceuticals INC. | $25.48 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.35 | 2024 | Lifevest |
| Atricure, INC. | $22.74 | 2025 | Atriclip Laa Exclusion System |
| Lantheus Medical Imaging, INC. | $21.67 | 2023 | Definity |
| Bayer Healthcare Pharmaceuticals INC. | $21.58 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $19.51 | 2025 | Cardiva Vascade 6/7f Vcs |
| Alnylam Pharmaceuticals INC. | $18.34 | 2025 | Onpattro |
| Pfizer INC. | $17.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ari Feinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.